Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

NCT01597973 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

467

Enrollment

OTHER

Sponsor class

Conditions

Pneumonia
Blood Stream Infection

Interventions

DRUG: colistin and meropenem
DRUG: colistin and placebo

Sponsor

University of Michigan